21 May 2013
Keywords: Ferring Pharma, Albireo, Elobixibat, Constipation, CIC, IBS-C
Article | 05 July 2012
Swiss drugmaker Ferring Pharmaceuticals has entered into a licensing agreement with Albireo AB, a Sweden-based biotechnology company spun out from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 July 2012
6 July 2012
20 May 2013
© 2013 thepharmaletter.com